A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

NCT02918929 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Presumptive NAFLD

Interventions

DRUG: EDP 305
DRUG: Placebo

Sponsor

Enanta Pharmaceuticals, Inc

Collaborators

[object Object]